Research unit
Project number
40713.1 IP-LS
Project title
Preclinical validation of PB002, a novel bacterial mix for the treatment of ulcerative colitis
Project status Finished
Start date 01.02.2020
End date 31.08.2021
Granted total costs 748'761.00  CHF
Section 60 Life Sciences
Project category Project
Research type Applied research and development
NABS classification Industrial production and technology
Research disciplines
100 % T410 Pharmaceuticals and related technologies

Last modification of the project